Endocrinology, Vol 125, 1739-1741, Copyright © 1989 by Endocrine Society

ARTICLES

GnRH receptors in human granulosa cells: anatomical localization and characterization by autoradiographic study

J Latouche, M Crumeyrolle-Arias, D Jordan, N Kopp, B Augendre-Ferrante, L Cedard and F Haour
Pharmacologie Neuro-Immuno-Endocrinienne, CNRS UA 1113, Institut Pasteur, Paris.

The presence of receptors for GnRH in human ovary has been investigated by quantitative autoradiography. Simultaneous visualization and characterization of specific receptors on frozen sections were obtained on six pairs of human ovaries. Among them only one exhibited a large preovulatory follicle. This dominant follicle exhibited a specific and high affinity binding capacity for 125I-GnRHa exclusively localized on the granulosa cell layer. Analysis of saturation curve indicates a Kd value of 0.22 nM and Bmax of 9.6 fmol/mg protein. In contrast LH-hCG binding sites were present in all antral follicles. These data demonstrate for the first time the presence of high affinity GnRH receptors in human granulosa cells at a late stage of follicular maturation.

This article has been cited by other articles:

				L. Dal Prato, A. Borini, G. Coticchio, M. Cattoli, and C. Flamigni Half-dose depot triptorelin in pituitary suppression for multiple ovarian stimulation in assisted reproduction technology: a randomized study Hum. Reprod., October 1, 2004; 19(10): 2200 - 2205. [Abstract] [Full Text] [PDF]

				J.W. Stephens, J.R. Katz, N. McDermott, A.B. MacLean, and P-M.G. Bouloux An unusual steroid-producing ovarian tumour: Case report Hum. Reprod., June 1, 2002; 17(6): 1468 - 1471. [Abstract] [Full Text] [PDF]

				J. A. Garcia-Velasco, V. Isaza, C. Vidal, A. Landazabal, J. Remohi, C. Simon, and A. Pellicer Human ovarian steroid secretion in vivo: effects of GnRH agonist versus antagonist (cetrorelix) Hum. Reprod., December 1, 2001; 16(12): 2533 - 2539. [Abstract] [Full Text] [PDF]

				L.D. Prato, A. Borini, M.R. Trevisi, M.A. Bonu, E. Sereni, and C. Flamigni Effect of reduced dose of triptorelin at the start of ovarian stimulation on the outcome of IVF: a randomized study Hum. Reprod., July 1, 2001; 16(7): 1409 - 1414. [Abstract] [Full Text] [PDF]

				O. Ortmann, J.M. Weiss, and K. Diedrich Embryo implantation and GnRH antagonists: Ovarian actions of GnRH antagonists Hum. Reprod., April 1, 2001; 16(4): 608 - 611. [Abstract] [Full Text] [PDF]

				S. K. Kang, C.-J. Tai, P. S. Nathwani, and P. C. K. Leung Differential Regulation of Two Forms of Gonadotropin-Releasing Hormone Messenger Ribonucleic Acid in Human Granulosa-Luteal Cells Endocrinology, January 1, 2001; 142(1): 182 - 192. [Abstract] [Full Text] [PDF]

				J. A. Garcia-Velasco, V. Isaza, A. Requena, Fco.J. Martinez-Salazar, A. Landazabal, J. Remohi, A. Pellicer, and C. Simon High doses of gonadotrophins combined with stop versus non-stop protocol of GnRH analogue administration in low responder IVF patients: a prospective, randomized, controlled trial Hum. Reprod., November 1, 2000; 15(11): 2292 - 2296. [Abstract] [Full Text] [PDF]

				The European Orgalutran Study Group, G. Borm, and B. Mannaerts Treatment with the gonadotrophin-releasing hormone antagonist ganirelix in women undergoing ovarian stimulation with recombinant follicle stimulating hormone is effective, safe and convenient: results of a controlled, randomized, multicentre trial Hum. Reprod., July 1, 2000; 15(7): 1490 - 1498. [Abstract] [Full Text] [PDF]

				R.H. Mehta and T.C. Anand Kumar Can GnRH agonists act directly on the ovary and contribute to cyst formation? Hum. Reprod., March 1, 2000; 15(3): 505 - 507. [Full Text] [PDF]

				C. Albano, J. Smitz, H. Tournaye, H. Riethmuller-Winzen, A. Van Steirteghem, and P. Devroey Luteal phase and clinical outcome after human menopausal gonadotrophin/gonadotrophin releasing hormone antagonist treatment for ovarian stimulation in in-vitro fertilization/intracytoplasmic sperm injection cycles Hum. Reprod., June 1, 1999; 14(6): 1426 - 1430. [Abstract] [Full Text] [PDF]

				Y. Lin, J. A. Kahn, and T. Hillensjo Is there a difference in the function of granulosa–luteal cells in patients undergoing in-vitro fertilization either with gonadotrophin-releasing hormone agonist or gonadotrophin-releasing hormone antagonist? Hum. Reprod., April 1, 1999; 14(4): 885 - 888. [Abstract] [Full Text] [PDF]

				H.-F. Chen, E.-B. Jeung, M. Stephenson, and P. C. K. Leung Human Peripheral Blood Mononuclear Cells Express Gonadotropin-Releasing Hormone (GnRH), GnRH Receptor, and Interleukin-2 Receptor {gamma}-Chain Messenger Ribonucleic Acids That Are Regulated by GnRH in Vitro J. Clin. Endocrinol. Metab., February 1, 1999; 84(2): 743 - 750. [Abstract] [Full Text]

				P. Morales Gonadotropin-Releasing Hormone Increases Ability of the Spermatozoa to Bind to the Human Zona Pellucida Biol Reprod, August 1, 1998; 59(2): 426 - 430. [Abstract] [Full Text]

				C. K. Welt, K. A. Martin, A. E. Taylor, G. M. Lambert-Messerlian, W. F. Crowley Jr., J. A. Smith, D. A. Schoenfeld, and J. E. Hall Frequency Modulation of Follicle-Stimulating Hormone (FSH) during the Luteal-Follicular Transition: Evidence for FSH Control of Inhibin B in Normal Women J. Clin. Endocrinol. Metab., August 1, 1997; 82(8): 2645 - 2652. [Abstract] [Full Text] [PDF]